SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001193125-23-303997
Filing Date
2023-12-27
Accepted
2023-12-27 16:16:06
Documents
10

Document Format Files

Seq Description Document Type Size
1 S-3 d640114ds3.htm S-3 376027
2 EX-4.15 d640114dex415.htm EX-4.15 301467
3 EX-4.18 d640114dex418.htm EX-4.18 97383
4 EX-4.19 d640114dex419.htm EX-4.19 99213
5 EX-4.20 d640114dex420.htm EX-4.20 86523
6 EX-5.1 d640114dex51.htm EX-5.1 25770
7 EX-23.1 d640114dex231.htm EX-23.1 1716
8 EX-FILING FEES d640114dexfilingfees.htm EX-FILING FEES 44460
9 GRAPHIC g640114g1227064511203.jpg GRAPHIC 2534
10 GRAPHIC g640114g30q47.jpg GRAPHIC 76294
  Complete submission text file 0001193125-23-303997.txt   1142508
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-276287 | Film No.: 231518118
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)